Mark Wegter

Mark Wegter is a Partner at EQT in Amsterdam, specializing in private equity, investments, and hedge funds. He has a successful track record of investing in companies like Affimed during their Series B funding round while previously serving as Managing Partner at Life Sciences Partners (LSP). Mark Wegter's career highlights include his current role as a Partner at EQT, where he focuses on private equity investments and his previous experience as Managing Partner at Life Sciences Partners (LSP), demonstrating expertise in managing investments in the life sciences sector.